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microscopy technique, The mioroscoplst wee blinded to the rotational speed 
of the samples, The numbers of aggregates 20-60 l~ m dlameter/ml blood are 
shown below as n functlen of Ihe retnllonsl speed with or without ReoPre '~'. 
Number of Plstolet Rotational Speed 
Aggrsgm= lOOk rpm lOOk rpm + RooPro 140k rpm Control (0 ram) 
20-00 I,m dis. 
meter/ml blood' 4131 ~ 3330 934 ¢ 715 420 ~ 435 240 ;t ;293 
R#n.go_ 444-13809 t 33-2011 t 11-17;2;2 03-1 ;222 
' n ,~ R0; ~ I;1(t Day,; p - 0,00;2 for ~11 comparisons, 
NOt ell blOOd samples responded ta RooPro, In 4/20 samples, RooPro 
d~raesaa tea number el plutetet aggregates oeused by the relating burr by 
loss then 20%, Plstolet aggregates In all nsmples subjected to lower speed 
worn decreased by grouter than 75%, (Rstlo of # of aggregates', 140k/160 + 
RooPro 0,89), 
Conclusion: This in vitro tasting suggests that Ihe use of the Roteblotor 
system et 140,000 rpm (ItS minimum approved speed) may be more eflootlve 
In reducing pletolot aggregation than ReoPro, Whether mduoad epeed will 
provide clinical benefit in mduelng slow flow and post prooedure omaline 
kisses elevation Is being investigated, 
~ Rotational Inemeaes Circulating Atheroctomy 
Platalet-Monoayte Complexes 
M,G, Tmuth, S,1, Simon, Z,,X, ,~' C,'=, ', ~mtlh, J, Mlckelson, N,S, Ktetman, 
F)~ College of Med¢tne, HOl~fon, TX, USA 
Rotational Athere~tomy (RA) feollllates the debutklng of various lesion types 
but Is asseslated with an i~resse In NQMI, Proposed mechanisms include 
plugging by debris and ptetalat (pit) actlvetlon, Using whole blood flow cytom. 
airy we competed several ma~ers of pit activation in peripheral blood', [pit. 
monocyte complexes, plt.neufrophll (PMN) complexes, P.selecttn (C062), 
and activated GP lib.life expression (PAC,1)] In patients undergoing RA with 
those undergoing coronary angloplazty (PTCA), peripheral angloplssty (PA), 
or coronary anglography (CA), No consistent increase attar the procedure 
could be detected fat ptt.PMN, CD,62, er PAC-t, However, plt.monocyls 
complexes Increased following RA', 
RA PA nTC^ CA 
Pm 140 .t ;2 13,0 ~ 1,5 5 7 i. O 12.4 ± ;2 
1 Hr Post 3~,2' -t 64 165 ~, 2 23 9 t a 3 193 ± 5.9 
24 Hr Post 15,2 ~ 26 98 .t 4,8 8!~ ~ 5.3 143 i 34 
'p • O.0Svs Pm 
Pg/monoc~la complexes represent a stable measure of pit ecttvetton in 
peripheral blood while direct assessment ol peripheral pit activation are less 
conclusive, Measurement of plVmonocyte complexes uggests that RA acti- 
vales pit more than PA, PTCA or CA. increased pit activation may represent 
a mechanism for the higher incidence of NQMI following RA, 
• Intrecoronary Adenosine Administered During 
Rotational Athoroctomy of Complex Lesions In 
Native Coronary Arterl le Reduce the Incidence of 
'no Reflow' Phenomenon 
G,P, Hanna, P, Yhlp, K, FuJlse, G,W, Schrelh, O,R, Resales, H,V. Anderson, 
R,W, Smaltlng, The University ol Texas Medical School and Hermann 
Hospital, HooMon, Texas, USA 
Background: Rotational athorectomy (RA) of complex, highly calcified lesions 
has been associated with a high incidence of 'no roflow' ranging from 6-15% 
and concomllant myocardial necrosis with adverse prognostic implications, 
There are no uniform strategies for preventing this complication, The role ol 
tntracoronary adenosine for the pmvenlion of this phenomenon during RA 
has net been tully evaluated. 
Methods: We studied the procedural outcome of 122 patients who un- 
derwent RA of complex native coronary artery lesions. Fifty two patients 
received no adenosine, but a veriely of other agents. Seventy patients re- 
ceived intracoronary adr, nosine boluses (24 mcg to 48 mcg prior to and after 
each RA run), There was no difference m the type of lesion studied, run time, 
or Burr to artery ratio (0.6--0.7) between the two groups. 
Results: Six patients without adenosine xpedenced 'no reflow' (11,6%) 
with resultant infarclion in the target artery territory, while only one of seventy 
patients (1,4%, p = 0,023) in the adenosine group experienced no rellow, No 
untoward complications were observed during adenosine ',nf~sion, 
Conclusion: Intracoronary adenosine bolus administered uring rotational 
atheractomy is easy, safe and may significantly reduce the incidence of 'no 
roflow' which may improve the 30 day outcome of this procedure. 
• Coronary After Rotational Atherectomy Slanting 
Vemus Coronary Stentlng Alone: 
An Anglogrephle Compsr l lon  
X. Wang, I. Mesas, A, Colombo, J, Moses. Centre Colomt~ Hospital, Milan 
Ilaly, Lanox Hill Hospital, New York NY, USA 
Purpose: To retrospeotlvoly compare the immediate and slx month anglo- 
graphic englographlo utcome for these two different approaches, 
Methods; A total of 178 pellents (270 lesions) who had stoats Implanted 
in de novo, non o~ludod vessels and had six month nnglogmpht¢ fogow 
up were classified Into two groups: steal alone (146 patients, 226 lesions) 
and rotostent (32 patients, 44 lesions), Acute and follow.up (FU) roeultl am 
shown In the table: 
Rate,tent Slant p vslue 
Lenten l~pe tB2+C) 9?,68% 66,0?% ~OCOt 
C~l¢ium 04.00% e.93% ~ O 001 
Pm mtemnc~ tram) ;2.9~  0~45 3 0 * 0.51 
Lesion length tram) 1;~,27 * 7.3r 11 Tt * 0.54 ns 
Post MLO (ram) 3.05 * O 56 3.0 t 054 ns 
Pos|%D~ 365 t 1037 e.10 :t t0.4;~ P4L 
FU MLO tram) I '/~ ~ 08~ 1 91 * 0.'19 ns 
FU %OEI 40 80 ~r ~;~ 380~ ~ 21 29 mi 
ACute (}sin (mm) ~}.1 ~ 0.59 1 ,e8 1 Q 53 ns 
Lslalass (ram) 1.33 ~ 071 1,1 ~i 0,)'2 ms 
LOSS ind~zt 0,ST * 037 O 50 ~: 0.44 ns 
Restenosts 40 91% 31.4~'% ns 
Conc/us/on: Despite the presence of morn uMaverabte ang~gre~ char- 
aetedst~(,'s in the lesions treated wflh mtablatton and stealing, the immediate 
and long.term angtographlc results were similar to those lesmns treated w~b 
stenttng alone, 
~ T h o  Ro l l  of Adjunctive Bal loon Oilltatlon in 
Directional Coronary Athemctemy Without 
Sublntimal Resection 
H, "Parent, 1", Suzuki, O, Kate, 1". Fulita, K. Ueno, S. Takase, K. Fulii, 
T, Aizawa, H, Kurogana, M. Kijima, H. Ode. Shags Me(P..al Center tot Adult 
D~seases, Moayama, Japan 
ABACAS (_Adjunctive I~elloon Angloplasty Following Coronary Athemctomy 
Study) is a prospective randomized multicenter teat to study whethm ag- 
gressive debulking with IVUS.guided DCA followed by adjunctive balloon 
dilatation reduces rastenosls. Restonosis rates were 23.6% for adjunctive 
balloon and 19,6% for DCA alone (n,s,). To elucidate the influence ol deep 
wall resection and adjunctive balloon on the restenosis rates, histological 
and angiographic study were peflormed in the same cohod. Accordlo 9 to the 
presence of subintimal resection and adjunchve balloon, eligible 194 pts were 
divided into four subgroups, DCA wtlh lotimal resection (D/I) group consisted 
ot 38 pts, DCA with subintimal resection (D/S) group ,57 pts, DCAroalloon 
with intlmal resection (D/liB) group 48 pts and DCAlbelloon with subintimal 
resection (D/S/B) group 53 pts. 
Results: QCA analysis revealed more (n.s.) late toss (D/I: 0.7 ± 0.5, D/S: 
0.9 ± 0.6, D/t/B: 1.2 + 0.7, D/S/B: 1,0 + 0.6 ram) and higher (n.s.) loss index 
(D/I: 49%, D/S: 59%, D///B: 64%, D/s/e: 50%) in D/I/B group than the other 
groups. Restenosis rate of D/I/B group was significantly higher than the other 
groups (D/l: 13.9%, D/S: 17.6%, D/Z~: 34.8%, D/S/S: 12,0%)(p < 0.05). 
Conclusion: Adjunctive balloon following DCA without subintimal resec- 
tion increased rastenosis rata. IVUS-guided complete removal of atheroma 
without adjunctive balloon may be the best strategy on DCA. 
1•0---- 1 Considerations in Use of Heparin, 
Adenosine,  K+ Channe l  Opener, and 
GPIla/ll lb Inhibit ion Dur ing Interventional 
Procedures 
Wednesday,  April 1, 1998, Noon-2 :00  p.m. 
Georg ia  World Congress Center,  West  Exhibit Hall Level 
Presentat ion Hour: Noon- l :00  p.m. 
• Prolonged Heparin Uncomplicated Coronary After 
Interventions: A Prospective Randomized Trial 
A. Garachemani. M. Fleisch, U. Kaufmann, B, Meier, Cardiology, University 
Hospital, Inselspital, Bern, Switzerland 
The aim of this trial was to evaluate if hepafin infusion after uncomplicated 
coronary interventions reduced the incidence of acute cardiac complications. 
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A total of 191 cons~utlve patients who underwent a successful PTCA were 
randomly assigned to re~ive eilher prolonged (heparin group, 100 pls.) of 
no postprocedure heparln (control group, 91 pts), The two treatment groups 
were comparable wdh respect to clinical and angtogt'aphic ¢heraoferistcs. 
Comlol gm~@ Hep,,n group p 
StenosmbelomPTCA (%1 74 t 16 72 t 15 ns 
S~a~f  PTCAI%I :~3 t 11 23 • 10 ns 
Mt, O tx~om FIrCA mm 09± 05 08$04 n~ 
MLDa~IFTCAmm ;~3 t 05 24 t 06 ns 
Stents 33136%) 33 (33%1 ns 
Myocan~l mla l~ 4% 3% ns 
C,kl~ 0 0 ns 
(:~e~th 1% 0 ns 
Va~ C0mlpb~ t % 3% nu 
Fou~ pal~nts in the Conllol grouP (4%) and 3 pal~nts m lhe hepann 
d~l  mine days aft~ me a-~m~on~ ~ vascu~r c o n ~  
in the ¢ontlro~ and ~ gn~u~ ~ m 1% an~t 3P= ot me patients, 
mspect,~/. 
Conctu~om: On~mn of ~ afte~ ~s lu l  PTCA w~h o~ 
slam ~l ion  in patmms wrlh ~ a~Kl unS~'~ble ~ d~l not mgn,f. 
Canl~ ~ me ~ of acute ~ compt~Cal~ns, ft a~ows Io~ 
eady sheam removal and pal~nt dmcharge and saves costs. It sheu~l be I~  
pa~y fo~ reut.~ paments. 
N~r!n-lndum~ 'n'~mmi~y~'~i Syndrome 
Con~tk~mg 1~-utamm~ Comnaw In~rven~ 
J.G Mofwam. K. Koflke-Marcha~ P.L Widow. S.G_ IEI~. EJ. Tapof 
Depa~ ot Can~,  Freedk:m~ Hospitad./.~ Heato~ 
~ T W , ~  Umle~ K~g~lom 
Hepann-mdUced ~ a sevem ~ synde~e me- 
dinted by a hepann-assooated plalelet-a¢lwalmg IgG, has bee~ ~lUe sludmd 
m lhe cot~ext el pefcet~-~m omona~ mtenmntion (PTC~). ~ 11/92 
and t(~J6, of 9486 patients (pts) who underwent PTCA. 69 (0.T3%) I~S (46 
ma~e; age68 ~+ 9 (SD) y) demonstrated tmpann-mduc~ I~e l~ aggregation 
assooated w~th absolute (94% of pts) o~ relative (5.6%) mrendx~cyto~-m~ 
Platelet cotmts lell by 60 ~: 18% from 234 ± 66K/.LtoS~ ± 40K~pL at 39  
2.8 days after commenong Lv. u~fractxmated hepann. ~ events 
OccmTed in 18.8%; lower limb artenal lhromtbosis. 4pls (1 requinng amputa- 
I~o~); lottel limb venous thrornbos~,, 5 pts; dialyze fistula mrombo~s. I I~: 
tatal mesentenc inlamtmn. I pt; recurrent inlracorona~/thrembus fon~abo~ 
w~h Q-wave ML I pt; and acute ~ 24 h) 11~ombos~ el I oill~e 24 ~ 
s-tents deployed (42%). w~h Q-wave MI in mis pt. P re t~-=~t  ~ asl:nnn 
(623%) of aspmn plus t~dol~line (28.9%). duration el hepann Irealment (23 
: 2.1 days), dose el hepann (1050 z 150 ./h) or prior hepann exposure 
(75.4%) where not ~ore  of degree ot fan in platetel count of occun-enoe 
of throcnbot)c events. ~ i c  events occurred in 3 of 19 pLs (15.8~,) 
who recetved aboximab and in 9 ol 50 pts (18%) who did not (p : NS) 
NO adddmnal thrombol¢ events oocurred among pts m where unfmctmnated 
hepann was subsMuted troth low mofecumr we~ht hepann (after excluding 
crossreactnnty; n = 7), a~Datroban (n = 1) or ancrod (n = 1). Skin hectors 
OCCUrred in 1 of 14 pls commenced on coumadin. 
Cot~usron: Hepann-mduced thrombocytopema complicating Coronary in- 
lenrentton results in a high hequency ot malor artenal anQ venous thrombct~ 
events, irrespectnm of (:Lose and dorabon of hepann, and despde Optimal 
antiplatelet herapy. 
I 1190-100 ] The Heparin In fus ion to Slanting (HIPS) Prior 
Trial: Procedural,  In-hospital, 30 Day, and six 
Month Clinical, Anglographic  and IVUS Results 
R.L. Wilensky, J.oF. Tanguay. S. Ire, A.L. Bartorelli, J Moses. D O. Williams. 
TA. Bucher. P. Gallant, H Wu, J.J. Popma. N, We~srnann, G.S. Mintz. 
A.V. Kaplan. M.B. Leon. Washington Hospital Center, Washington. DC. USA 
Local delivery, ot hepann is a promising approach to reduce in-slant testa- 
nests. Slant-lumen volume as measured by intravaScular ultrasound (IVUS) 
provides a means to efticiently evaluate the impact of new therapies on 
in-stent restonosis We studied the impact of locally delivered heparin on 
in-stent rostenosis as measured b~., IVUS in the HIPS study, a multi-cen- 
ter, randomized conmlled trial. A total of 179 patients were randomized to 
receive heparin (5000 U in 5 ml) either intracoronary tic/control) via the 
guide catheter or intramural via the InfusaSleevo (LocalMed, Inc.) pdo: to 
single Palmaz-Schatz slant placement. Baseline demographic, clinical and 
angiogrephic parameters were evenly distributed with the exception of initial 
Minimal Luminal Diameter, 1.12 ± 0.34 vs 0,99 ± 0.37 ram, in the ic/control 
and intramural groups respectively (p .  0.03), Core ang~o~ral~l~ labomlo~ 
evaluation of the intramural group rav~aNK118 NHLBI Gra¢le ~ 
tollow~ng inilial PTCA ot wh~h 1 progreued toflowtng local h(~Ntf~ thera~/. 
there were no significant d~fter~-,;,~ in the EUC d~mc~o~ m the two groups 
pnor fo flt0nt placement, 33% (P/control) vs 29% (irtramural) l~oo~k~ral 
o~t¢omes as mea=um0 W timbal, angiogra~ and hqJS criterta were ~m- 
ilar between, ~ (cltn¢,l au~= 98,9 v~ 98~ pttter~ m the ¢,~ntm 
ar~ intramural grou~ mt~"t~y) ,  In.lx~q~l ~ m~.  1,1% (wcomml) 
v~ 1-2% (intramural) and 30 ¢lav coe~l~ ( r~e mlpo~e<l) w~m ~m~. 
tar S~ month clinical, ang~grapt~ and IVU$ !ollow,t~o will be O0mlple~ m 
J~ngaw 1998, 
Conc/~.- Local delivery ot I~pann v~ the ~,aS lee~e m 
and Mle, The ~Ct  ot 11~ mempy on n~no~ ~lowmg mer~ l~acem~ 
c~ten'nine~ by an~u~¢ and IVU$ paramelera wdl be ~ 
mmm1=In m~1 ~11-'1~mm1~In A¢11vlty 0urU~ 
l~mlan~u!'rnlnilumlmll Comnmy 
Anglo,fury 
WK Laskey, K Zawac~0, R Lm~, N. Calamuno, D. McCanon, WG Herzog. 
t /nn~ ot Ma./~n~ M~V.a /S~ Ba/~mom Ma~ar~ USA 
Back~'oun(t The mmb~tory enecm el hepann (H) on me coagulation symem 
am medialed by I~e ~ ¢4 an~l~mmbm III (AT III). L3me is ke~m~ of 
Ihe a#e~ el !~1~'~ H on I rans .¢a~ AT III acrid/and no ~ m 
avadab~ on l~ma-¢a~0Bac AT III followlng leoal H deINery dunng PTCA 
~#nmo~: We analyzeO pat t i  symm¢ ammai (SA) and co~t~,V sinus 
(CS) beoed samples m 9 pa~lei~ undmgomg PTCA. AT I11and Fp~ a ma,.ke~ 
of 8~d~n acUvey, was measmed p~or to com.~ary mofnmmntmmn (~) .  
5 ~ foflowWtg 10,000 traits of ~ H (SH), 5 minules after 
completion of PTCA (pro LH), a~d 5 minutes after 4,000 uftit= of H c le~d 
to ff~e PTCA uite wa a ~ infusion catheter (peru LH). 
ResuRs: 
base SH ~e LH post I.H 
CSAT Ill (%) 71 t 16 (~9 ~: 16 75 ± 27 97 i 23 a 
AT III |%1 67 ~: 19 64 t 25 79 ~: 20  80 t- !~  
CS FpA (n~1111) 100  t 2 I 5.9 ~: 3.8 22  ¢ 3~. 1 5 ± 2%: 
SA F~A (n~m~ 97 : 19  5.B ~: 38  4B  ¢ 34  46  ~r 26  d 
, ~ . . . . .  ~ =p-  0 ( ]~]01 ,°=p 0001byANOVAi  
~ :  1) SH donng PTCA results m oL~ectable i,-,~ieases m born 
SA & CS AT nl ~ and decreases in SA & CS FpA and 2) I.H results 
in fmlher mcm.ased local (CS) AT Ill aclnnty and dimlmshed FpA release. 
These results support enhanced and ~e-speof¢ hepann actn,tly when ap- 
rr,r,stered locally. 
~ D o e =  ~ Wire Intravenous .epa~n 
Produces any Angiogmphk: hnpmmm~t in 
Patients Admitted With Unstable Angina? 
F. Cura. R. Pimmo, L. Guzman, L Pallia. J. Fernandez. G. Marchefti, 
A Palacios, J. I~elam~. Instn~to CardloYasc'u~r de Buenos A/res, , ~  
The ~esence of ~racomnaw n~ombus is a c~mmon ~l ing  m pe~ents (~s) 
un~ff~:,r,~ can~an came~mza~n de~g unstable angina (UA). Coronary 
(PTCA) dunng this s~ing has been as~c~ted w~ a s~r,T,;~i 
inc~mem of complication. Tempera~ tream~t w~m intravenous (IV) hep- 
ann prior to proceed with the PTCA has been postulated as a safer way in 
thin pts. The i~.'mose of mrs stuo'y was to evatuate me ~ c t '~ ,~ 
alter the l ' re~ ~ Ilepann during 48 to ~ hours (hnS) in 10ts Brimmed 
with UP,, From 08/96 to 08/97. we prospectively evaluale 23 ~s w~h UA who 
had the ltrsl Coronary ang~grem (angm) wdhin 24 hrs (mean of 17.8 ± 6.9 
hm) of the last ~ of class IV angina and the second ang~o between 
48 to 96 hrs (mean of 533 ± 17.4 hrs) after the treatment of IV heparin, 
The presence 01 thren~us, thrembus SCOre. the TIMI flow, the frame count 
measurement, percentage of stenoszs. ACC score and all the morphologic 
characteristics were evaluated in both angto by two blinded observers. (An- 
giographic thrombus was classified as 0 = no thrombus, 1 = haziness, 2--4 
= definitnte thfomb*us with size < 0.5, 0.5-1.5, > 1.5 the reference diameter, 
respectn/ely). Both anglo did not show any stgnif~ant changes. 
Fm~t a ~ m  Second angTogram p value 
Thrombus (+) 565% 56.5% NS 
Thrombus Score 2.23 • 1.3 207  _~ 1 04 0.52. 
TIMI flow 2.65 ± 0.57 265  ± 0.64 NS 
Frame Count 50.3 • 33 40.4 ± 29 0.29 
Thrombus Size 363  ~: 1.7 mm 2.6 ± 1.7 mm 027 
% Stenosm 69 ± 7.8% 679 ~ 10 8% 069 
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